Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. NeuroMetrix, Inc.
  6. Company
    NURO   US6412558073

NEUROMETRIX, INC.

(NURO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
Business Summary
Logo NeuroMetrix, Inc.
NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. Its products include ADVANCE NCS/EMG System (the ADVANCE System), Quell, SENSUS and DPNCheck. Quell is a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems. The SENSUS pain therapy device, the technological predecessor to Quell, is a prescription neuro-stimulation device based on transcutaneous electrical nerve stimulation (TENS) for relief of chronic, intractable pain. DPNCheck is a quantitative nerve conduction test. ADVANCE System is a platform for the performance of traditional nerve conduction studies.

Number of employees : 20 people.
Sales per Business
20192020Delta
Medical Equipment and Consumables9.27100%7.38100% -20.43%
USD in Million
Sales per region
20192020Delta
United States8.0787%6.2785% -22.26%
Non-United States1.2113%1.1115% -8.19%
USD in Million
Managers
Name Title Age Since
Shai N. Gozani, Dr. Chairman, President & Chief Executive Officer 55 -
Thomas T. Higgins Chief Financial Officer, Treasurer & Senior VP 68 -
David E. Goodman, Dr. Independent Director 63 2004
Nancy E. Katz Independent Director 61 2010
David van Avermaete Independent Director 68 2013
Michael J. MacDonald Senior VP & General Manager-Diagnostics - 2017
Xuan Kong, Dr. Chief Data Scientist - 2017
Francis X. McGillin Chief Commercial Officer & Senior Vice President 59 2014
Members of the board
Name Title Age Since
Shai N. Gozani, Dr. Chairman, President & Chief Executive Officer 55 -
David E. Goodman, Dr. Independent Director 63 2004
Nancy E. Katz Independent Director 61 2010
David van Avermaete Independent Director 68 2013
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 5,628,907 5,595,927 99.4% 0 0.0% 99.4%
Shareholders
NameEquities%
Topline Capital Management LLC (Investment Management) 542,240 9.63%
Renaissance Technologies LLC 150,000 2.66%
Sabby Capital LLC 82,250 1.46%
The Vanguard Group, Inc. 66,234 1.18%
Dimensional Fund Advisors LP 45,700 0.81%
Wedbush Securities, Inc. (Investment Management) 34,841 0.62%
Acadian Asset Management LLC 29,969 0.53%
Citadel Advisors LLC 28,787 0.51%
Shai N. Gozani 24,630 0.44%
Thomas T. Higgins 23,659 0.42%
Brand Portfolio
In partnership withAllbrands.markets
More brands of NeuroMetrix, Inc.
Sector Other Medical Equipment, Supplies & Distribution